2 results
Approved WMOCompleted
1. Overall survival (primary efficacy endpoint)2a. Efficacy: progression-free survival (PFS), overall response rate (ORR = CR + PR), and a clincal benefit rate (CBR) will be evaluated as CR + PR + SD for at least 3 months.2b. Safety: adverse events…
Approved WMORecruiting
Purpose of the clinical study: To evaluate the effectiveness, safety and usability of real time continuous glucose monitoring (rCGM) in neonatal intensive care (NICU)Primary objective:* To evaluate the effectiveness of rCGM in the regulation of…